|
|
|
|
Rat PAI-1 Price : 550 € For Research Use Only ____________________________________________________________________________________________________________ Please read all instructions carefully before beginning this assay. Store PAI-1 Standard Primary Antibody at –70º C. Store remaining components at 4º C. ____________________________________________________________________________________________________________ DESCRIPTION ____________________________________________________________________________________________________________ Plasminogen Activator Inhibitor-1 (PAI-1) is a glycoprotein and member of the serine proteinase inhibitor (serpin) superfamily. PAI-1 is the primary inhibitor of tissue-type plasminogen activator (tPA) and the urokinase-type plasminogen activator (uPA). This inhibition exhibits antiproteolytic properties that can lead to myocardial infarction, thromboembolic disease with elevated levels of PAI-1. Additionally, PAI-1 is thought to play a role in the function of tissue remodeling and tumor metastasis. ____________________________________________________________________________________________________________ PRINCIPLE OF ASSAY ____________________________________________________________________________________________________________ This is an ELISA (Enzyme-Linked Immunosorbent Assay) for the quantitative analysis of PAI-1 levels in biological fluid. This test kit operates on the basis of sandwich ELISA where active PAI-1 complexes with uPA and is quantitfied with the use of an HRP labeled secondary antibody. The functional or active PAI-1 binds to the uPA coated on the well of the microtiter plate. The latent and complexed forms of PAI-1 will not bind and are discarded at a later washing step. Next, PAI-1 primary antibody is added to the wells binding to the captured PAI-1 on the microtiter plate. HRP conjugated secondary antibody is then added for detection of the active PAI-1. Quantitative test results are obtained by the measure and comparison of the sample and standard absorbance readings. ____________________________________________________________________________________________________________ MATERIALS PROVIDED ____________________________________________________________________________________________________________ 1. Rat PAI-1 Standard: 1 vial. 2. Substrate: 10 mL. Stabilized 3,3', 5,5' Tetramethylbenzidine (TMB) plus Hydrogen Peroxide (H 2O2) in a single bottle.3. Anti-PAI-1 Primary Antibody: 1 vial of anti-rat PAI-1 antibody. 4. HRP Secondary Antibody: 1 vial of HRP conjugated secondary antibody. 5. Coated Plate: A 96 well microplate with PAI-1 capture antibody precoated on each well. The plate is ready for use as is. DO NOT WASH!____________________________________________________________________________________________________________ MATERIALS NEEDED BUT NOT PROVIDED ____________________________________________________________________________________________________________ 1. 1 N H 2SO4.2. TBS buffer (see Reagent Preparation). 3. Blocking buffer (see Reagent Preparation). 4. Wash buffer (see Reagent Preparation). 5. DI water. 6. Microplate reader with 450 nm filter. 7. Microplate shaker with uniform horizontal circular movement up to 300 rpm. 8. Beakers, flasks, cylinders, etc. required for preparation of reagents. 9. Precision pipettes that range from 10 mL-1000 mL and disposable tips.10. Plastic film or plate cover to cover plate during incubation. ____________________________________________________________________________________________________________ WARNINGS AND PRECAUTIONS ____________________________________________________________________________________________________________ 1. DO NOT use components beyond expiration date.2. DO NOT mix any reagents or components of this kit with any reagents orcomponents of any other kit. This kit is designed to work properly as provided. 3. DO NOT pipette reagents by mouth.4. Always pour substrate out of the bottle into a clean test tube - DO NOT pipette out ofthe bottle (if your tip is unclean you could contaminate your substrate). 5. All specimens should be considered potentially infectious. Exercise proper handling precautions. 6. DO NOT smoke, eat or drink in areas where specimens or reagents are being handled.7. Use aseptic technique when opening and removing reagents from vials and bottles. 8. Keep plate covered except when adding reagents, washing or reading. 9. Kit components should be stored as instructed when not in use. ____________________________________________________________________________________________________________ PROCEDURAL NOTES ____________________________________________________________________________________________________________ 1. Always use new pipette tips for the buffer, conjugate, standards, samples etc. 2. Before pipetting a reagent, rinse the pipette tip three times with that reagent (i.e. fill the tip with the desired amount of reagent and dispense back into the same vial - repeat 2 times). Now the tip is properly rinsed and ready to dispense the reagent into your well or test tube. 3. When pipetting into the wells, DO NOT allow the pipette tip to touch the inside of the well, or any of the reagents already in the well - this can cause cross contamination. 4. Standards and samples should be assayed in duplicate. 5. To quantitate, always run a standard curve when testing samples. 6. Gently mix specimens and reagents before use. Avoid vigorous agitation. 7. Before taking an absorbance reading, wipe the outside bottom of the wells with a lintfree wiper to remove dust and fingerprints. 8. Desiccant bag must remain in foil pouch with unused strips. Keep pouch sealed when not in use to maintain a dry environment. Seal with a heat sealer. If a heat sealer is not available, thoroughly close the open end with tape. Remove excess air before sealing. 9. If not using the entire plate at once, then prepare only the appropriate amount of standard and primary antibody. The remaining stock solutions should then be refrozen and stored at –70 °C.____________________________________________________________________________________________________________ SAMPLE PREPARATION ____________________________________________________________________________________________________________ Samples should be collected using trisodium citrate, acidified citrate or Stabilite tm(DiaPharma) collection media. Collection should be in accordance with the collection vials manufacturers instructions or in a 1:10 ratio of collection media to blood. Immediately, upon collection of blood, the samples should be centrifuged at 3000 x g. This should ensure the removal of platelets as they can release PAI-1 that in turn complexes with uPA. The plasma can be transferred to a clean plastic tube and stored frozen for up to one month. Samples are stable for approximately 24 hours when stored at 4 ° C with theSabilyte tm media or one month if stored at -20° C.Note: Detergents such as Triton X cause interference with the assay. If using detergent extracted samples, it is necessary to dialyze the samples overnight to remove the detergent. ____________________________________________________________________________________________________________ REAGENT PREPARATION ____________________________________________________________________________________________________________ The following solutions should be prepared fresh before starting the assay. -TBS Buffer: 0.10 M TRIS, 0.15 M NaCl, pH 7.4 -Blocking Buffer: 3% BSA in TBS buffer. -Wash Buffer: 0.05% Tween, 0.1 % BSA in TBS buffer. ____________________________________________________________________________________________________________ TEST PROCEDURES ____________________________________________________________________________________________________________ Note: This assay should be performed at room temperature. 1. Remove microplate from the bag. 2. Prepare standards as indicated in the provided dilution table. Note: The standards should be applied to the plate immediately upon preparation. 3. Add 100 mL of standards or unknowns to each well omitting wells for later use. SeeScheme I for suggested template design. 4. Shake the plate at 300 rpm on a plate shaker for 30 minutes. 5. Wash wells according to the following wash procedure: a. Remove contents of the plate by inversion into an appropriate disposal device. b. Tap out remaining contents of the plate onto a lint free paper towel. c. Add 300 mL of wash buffer.d. Let stand for 2-3 minutes. e. Repeat procedure 2 more times then proceed to step "f". f. Remove contents of the plate by inversion into an appropriate disposal device. g. Tap out the remaining contents of the plate onto a lint free paper towel then proceed to step 6. Note: The decanted wells should be void of visible moisture before proceeding. If moisture is still visible then follow step "g" until satisfactory results are obtained. 6. Add entire vial of primary antibody to 10 mL of the 3% BSA blocking buffer to make a working concentation. 7. Add 100 mL of diluted primary antibody to each well.8. Shake plate at 300 rpm on the plate shaker for 30 minutes. 9. Wash wells according to step 5 located above in this section. 10. Add 3 mL of secondary antibody to 10 mL of the 3% BSA blocking buffer.11. Add 100 mL of the working concentration secondary antibody to each well.12. Shake plate at 300 rpm on the plate shaker for 30 minutes. 13. Wash wells according to step 5 located above in this section. 14. Add 100 mL of TMB substrate to each well and allow to incubate for 10 minutes.15. Quench reaction with 50 mL per well of 1 N H2SO4 and read plate at 450 nm.16. If accounting for substrate background, use 2 to 8 wells as blanks with only substrate in the wells (150 mL/well). Subtract the average of these absorbance values from theabsorbance values of the wells being assayed. NOTE: Some microplate readers can be programmed to do these subtractions automatically when reading the plate. Consult your instrument manual. Scheme I ____________________________________________________________________________________________________________ CALCULATIONS ____________________________________________________________________________________________________________ 1. Subtract the average O.D. value of the blank wells (BLK) from all other pairs of wells. 2. Average the O.D. values for each pair of duplicate wells. 3. Plot a standard curve using the average O.D. value for each standard value versus the concentration of standard. 4. Determine the concentration of each unknown by interpolation from the standard curve. 1 2 3 4 5 6 7 8 9 10 11 12 A S1 S2 S3 S4 S5 S6 S7 S8 U1 U2 U3 U4 B S1 S2 S3 S4 S5 S6 S7 S8 U1 U2 U3 U4 C U5 U6 U7 U8 U9 U10 U11 U12 U13 U14 U15 U16 D U5 U6 U7 U8 U9 U10 U11 U12 U13 U14 U15 U16 E U17 U18 U19 U20 U21 U22 U23 U24 U25 U26 U27 U28 F U17 U18 U19 U20 U21 U22 U23 U24 U25 U26 U27 U28 G U29 U30 U31 U32 U33 U34 U35 U36 U37 U38 U39 BLK H U29 U30 U31 U32 U33 U34 U35 U36 U37 U38 U39 BLK ____________________________________________________________________________________________________________ ____________________________________________________________________________________________________________ PERFORMANCE CHARACTERISTICS ____________________________________________________________________________________________________________ Assay Range: 0.0- 50 ng/mL Samples with uPA levels higher than 50 ng/mL should be diluted in similar media devoid of active uPA. ____________________________________________________________________________________________________________ REFERENCES ____________________________________________________________________________________________________________ 1. Declerck, P.J., et al. J Intern Med (1994) 235:4250432 2. Winman, B., et al. Scand J Clin Lab Invest Suppl (1999) 230:23-31 3. Winman, B., et al. Thomb Haemostas (1984) 5-1:R9-R17 4. Colucci, M., et al. J Clin Invest (1985) 75:818-824 5. Kruithof, E. K., et al. Blood (1987) 70:1645-1653 6. Ranby, M., et al. Fribrinolysis (1990) 4:54-55 _______________________________________________________________________ GUARANTEE AND LIMITATION OF REMEDY ____________________________________________________________________________________________________________ Oxford Biomedical Research, Inc. makes no guarantee of any kind, expressed or implied, which extends beyond the description of the material in this ELISA kit, except that these materials and this kit will meet our specifications at the time of delivery. Buyer's remedy and Oxford Biomedical Research, Inc.'s sole liability hereunder is limited to, at Oxford Biomedical Research, Inc.'s option, refund of the purchase price of, or the replacement of, material that does not meet our specification. By acceptance of our products, Buyer indemnifies and holds Oxford Biomedical Research, Inc. harmless against, assumes all liability for the consequence of its use or misuse by the Buyer, its employees, or others. Said refund or replacement is conditioned of Buyer notifying Oxford Biomedical Research, Inc. within (30) days of the receipt of product. Failure of Buyer to give said notice within said thirty (30) days shall constitute a waiver by the Buyer of all claims hereunder with respect to said material(s). |
|
|